Global Sports Medicine Physician Survey - 2014
iData’s Global Physician Surveys are conducted by highly trained moderators with years of experience in applying iData’s rigorous methodology to ensure balanced responses and to elicit keen insight from physicians, surgeons, specialists and other medical professionals. iData’s Global Physician Surveys are used to garner brand awareness, product preferences, message feedback and positioning. iData’s Physician Surveys allow the inclusion of a diverse range of medical professionals in broader geographical areas. They also eliminate group bias and allow for interactive one-on-one feedback as well as flexibility to expose the respondent to interactive or static media.
RESEARCH METHODOLOGY
1.1 RESEARCH OVERVIEW
1.2 RESEARCH SERVICES
1.3 SURVEY METHODOLOGY
UNITED STATES
2.1 U.S. HYALURONIC ACID VISCOSUPPLEMENTATION
2.1.1 Physician Average Years of Practice in the U.S.
2.1.2 Clinical Settings in the U.S.
2.1.3 HA Viscosupplementation Brands in the U.S.
2.1.4 HA Viscosupplementation Injection Trends in the U.S.
2.1.5 HA Viscosupplementation Brand Purchasing Trends in the U.S.
2.1.6 Brand Adoption Trends in the U.S.
2.1.7 Purchasing Channel Trends in the U.S.
2.2 U.S. PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
2.2.1 PRP & cBMA Usage in the U.S.
2.2.2 cBMA Brands in the U.S.
2.2.3 PRP Brands in the U.S.
2.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, U.S.
CANADA
3.1 CANADA HYALURONIC ACID VISCOSUPPLEMENTATION
3.1.1 Physician Average Years of Practice in Canada
3.1.2 Clinical Settings of Respondents in Canada
3.1.3 HA Viscosupplementation Brands in Canada
3.1.4 HA Viscosupplementation Injection Trends in Canada
3.1.5 HA Viscosupplementation Brand Purchasing Trends in Canada
3.1.6 Brand Adoption Trends in Canada
3.1.7 Purchasing Channel Trends in Canada
3.2 CANADA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
3.2.1 PRP & cBMA Usage in Canada
3.2.2 cBMA & PRP Brands in Canada
3.2.3 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Canada
UNITED KINGDOM
4.1 U.K. HYALURONIC ACID VISCOSUPPLEMENTATION
4.1.1 Physician Average Years of Practice in the U.K.
4.1.2 Clinical Settings in the U.K.
4.1.3 HA Viscosupplementation Brands in the U.K.
4.1.4 HA Viscosupplementation Injection Trends in the U.K.
4.1.5 HA Viscosupplementation Brand Purchasing Trends in the U.K.
4.1.6 Brand Adoption Trends in the U.K.
4.1.7 Purchasing Channel Trends in the U.K.
4.2 U.K. PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
4.2.1 PRP & cBMA Usage in the U.K.
4.2.2 cBMA & PRP Brands in the U.K.
4.2.3 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, U.K.
ARGENTINA
5.1 ARGENTINA HYALURONIC ACID VISCOSUPPLEMENTATION
5.1.1 Physician Average Years of Practice in Argentina
5.1.2 Clinical Settings in Argentina
5.1.3 HA Viscosupplementation Brands in Argentina
5.1.4 HA Viscosupplementation Injection Trends in Argentina
5.1.5 HA Viscosupplementation Brand Purchasing Trends in Argentina
5.1.6 Brand Adoption Trends in Argentina
5.1.7 Purchasing Channel Trends in Argentina
5.2 ARGENTINA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
5.2.1 PRP & cBMA Usage in Argentina
5.2.2 cBMA Brands in Argentina
5.2.3 PRP Brands in Argentina
5.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Argentina
BRAZIL
6.1 BRAZIL HYALURONIC ACID VISCOSUPPLEMENTATION
6.1.1 Physician Average Years of Practice in Brazil
6.1.2 Clinical Settings in Brazil
6.1.3 HA Viscosupplementation Brands in Brazil
6.1.4 HA Viscosupplementation Injection Trends in Brazil
6.1.5 HA Viscosupplementation Brand Purchasing Trends in Brazil
6.1.6 Brand Adoption Trends in Brazil
6.1.7 Purchasing Channel Trends in Brazil
6.2 BRAZIL PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
6.2.1 PRP & cBMA Usage in Brazil
6.2.2 cBMA Brands in Brazil
6.2.3 PRP Brands in Brazil
6.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Brazil
COLOMBIA
7.1 COLOUMBIA HYALURONIC ACID VISCOSUPPLEMENTATION
7.1.1 Physician Average Years of Practice in Colombia
7.1.2 Clinical Settings in Colombia
7.1.3 HA Viscosupplementation Brands in Colombia
7.1.4 HA Viscosupplementation Injection Trends in Colombia
7.1.5 HA Viscosupplementation Brand Purchasing Trends in Colombia
7.1.6 Brand Adoption Trends in Colombia
7.1.7 Purchasing Channel Trends in Colombia
7.2 COLOMBIA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
7.2.1 PRP & cBMA Usage in Colombia
7.2.2 cBMA Brands in Colombia
7.2.3 PRP Brands in Colombia
7.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Colombia
VENEZUELA
8.1 VENEZUELA HYALURONIC ACID VISCOSUPPLEMENTATION
8.1.1 Physician Average Years of Practice in Venezuela
8.1.2 Clinical Settings in Venezuela
8.1.3 HA Viscosupplementation Brands in Venezuela
8.1.4 HA Viscosupplementation Injection Trends in Venezuela
8.1.5 HA Viscosupplementation Brand Purchasing Trends in Venezuela
8.1.6 Brand Adoption Trends in Venezuela
8.1.7 Purchasing Channel Trends in Venezuela
8.2 VENEZUELA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
8.2.1 PRP & cBMA Usage in Venezuela
8.2.2 cBMA Brands in Venezuela
8.2.3 PRP Brands in Venezuela
8.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Venezuela
MEXICO
9.1 MEXICO HYALURONIC ACID VISCOSUPPLEMENTATION
9.1.1 Physician Average Years of Practice in Mexico
9.1.2 Clinical Settings in Mexico
9.1.3 HA Viscosupplementation Brands in Mexico
9.1.4 HA Viscosupplementation Injection Trends in Mexico
9.1.5 HA Viscosupplementation Brand Purchasing Trends in Mexico
9.1.6 Brand Adoption Trends in Mexico
9.1.7 Purchasing Channel Trends in Mexico
9.2 MEXICO PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
9.2.1 PRP & cBMA Usage in Mexico
9.2.2 cBMA Brands in Mexico
9.2.3 PRP Brands in Mexico
9.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Mexico
DOMINICAN REPUBLIC
10.1 DOMINICAN REPUBLIC HYALURONIC ACID VISCOSUPPLEMENTATION
10.1.1 Physician Average Years of Practice in Dominican Republic
10.1.2 Clinical Settings in Dominican Republic
10.1.3 HA Viscosupplementation Brands in Dominican Republic
10.1.4 HA Viscosupplementation Injection Trends in Dominican Republic
10.1.5 HA Viscosupplementation Brand Purchasing Trends in Dominican Republic
10.1.6 Brand Adoption Trends in Dominican Republic
10.1.7 Purchasing Channel Trends in Dominican Republic
10.2 DOMINICAN REPUBLIC PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
10.2.1 PRP & cBMA Usage in Dominican Republic
10.2.2 cBMA Brands in Dominican Republic
10.2.3 PRP Brands in Dominican Republic
10.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Dominican Republic
JORDAN
11.1 JORDAN HYALURONIC ACID VISCOSUPPLEMENTATION
11.1.1 Physician Average Years of Practice in Jordan
11.1.2 Clinical Settings in Jordan
11.1.3 HA Viscosupplementation Brands in Jordan
11.1.4 HA Viscosupplementation Injection Trends in Jordan
11.1.5 HA Viscosupplementation Brand Purchasing Trends in Jordan
11.1.6 Brand Adoption Trends in Jordan
11.1.7 Purchasing Channel Trends in Jordan
11.2 JORDAN PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
11.2.1 PRP & cBMA Usage in Jordan
11.2.2 cBMA Brands in Jordan
11.2.3 PRP Brands in Jordan
11.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Jordan
INDIA
12.1 INDIA HYALURONIC ACID VISCOSUPPLEMENTATION
12.1.1 Physician Average Years of Practice in India
12.1.2 Clinical Settings in India
12.1.3 HA Viscosupplementation Brands in India
12.1.4 HA Viscosupplementation Injection Trends in India
12.1.5 HA Viscosupplementation Brand Purchasing Trends in India
12.1.6 Brand Adoption Trends in India
12.1.7 Purchasing Channel Trends in India
12.2 INDIA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
12.2.1 PRP & cBMA Usage in India
12.2.2 cBMA Brands in India
12.2.3 PRP Brands in India
12.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, India
NORTH AMERICA
13.1 NORTH AMERICA HYALURONIC ACID VISCOSUPPLEMENTATION
13.1.1 Physician Average Years of Practice in North America
13.1.2 Clinical Settings in North America
13.1.3 HA Viscosupplementation Brands in North America
13.1.4 HA Viscosupplementation Injection Trends in North America
13.1.5 HA Viscosupplementation Brand Purchasing Trends in North America
13.1.6 Brand Adoption Trends in North America
13.1.7 Purchasing Channel Trends in North America
13.2 NORTH AMERICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
13.2.1 PRP & cBMA Usage in North America
13.2.2 cBMA Brands in North America
13.2.3 PRP Brands in North America
13.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, North America
SOUTH AMERICA
14.1 SOUTH AMERICA HYALURONIC ACID VISCOSUPPLEMENTATION
14.1.1 Physician Average Years of Practice in South America
14.1.2 Clinical Settings in South America
14.1.3 HA Viscosupplementation Brands in South America
14.1.4 HA Viscosupplementation Injection Trends in South America
14.1.5 HA Viscosupplementation Brand Purchasing Trends in South America
14.1.6 Brand Adoption Trends in South America
14.1.7 Purchasing Channel Trends in South America
14.2 SOUTH AMERICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
14.2.1 PRP & cBMA Usage in South America
14.2.2 cBMA Brands in South America
14.2.3 PRP Brands in South America
14.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, South America
CENTRAL AMERICA & THE CARRIBEAN
15.1 SOUTH AMERICA & THE CARIBBEAN HYALURONIC ACID VISCOSUPPLEMENTATION
15.1.1 Physician Average Years of Practice in Central America & the Caribbean
15.1.2 Clinical Settings in Central America & the Caribbean
15.1.3 HA Viscosupplementation Brands in Central America & the Caribbean
15.1.4 HA Viscosupplementation Injection Trends in Central America & the Caribbean
15.1.5 HA Viscosupplementation Brand Purchasing Trends in Central America & the Caribbean
15.1.6 Brand Adoption Trends in Central America & the Caribbean
15.1.7 Purchasing Channel Trends in Central America & the Caribbean
15.2 CENTRAL AMERICA & THE CARIBBEAN PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
15.2.1 PRP & cBMA Usage in Central America & the Caribbean
15.2.2 cBMA Brands in Central America & the Caribbean
15.2.3 PRP Brands in Central America & the Caribbean
15.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Central America & the Caribbean
WESTERN EUROPE
16.1 WESTERN EUROPE HYALURONIC ACID VISCOSUPPLEMENTATION
16.1.1 Physician Average Years of Practice in Western Europe
16.1.2 Clinical Settings in Western Europe
16.1.3 HA Viscosupplementation Brands in Western Europe
16.1.4 HA Viscosupplementation Injection Trends in Western Europe
16.1.5 HA Viscosupplementation Brand Purchasing Trends in Western Europe
16.1.6 Brand Adoption Trends in Western Europe
16.1.7 Purchasing Channel Trends in Western Europe
16.2 WESTERN EUROPE PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
16.2.1 PRP & cBMA Usage in Western Europe
16.2.2 cBMA Brands in Western Europe
16.2.3 PRP Brands in Western Europe
16.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Western Europe
EASTERN EUROPE
17.1 EASTERN EUROPE HYALURONIC ACID VISCOSUPPLEMENTATION
17.1.1 Physician Average Years of Practice in Eastern Europe
17.1.2 Clinical Settings in Eastern Europe
17.1.3 HA Viscosupplementation Brands in Eastern Europe
17.1.4 HA Viscosupplementation Injection Trends in Eastern Europe
17.1.5 HA Viscosupplementation Brand Purchasing Trends in Eastern Europe
17.1.6 Brand Adoption Trends in Eastern Europe
17.1.7 Purchasing Channel Trends in Eastern Europe
17.2 EASTERN EUROPE PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
17.2.1 PRP & cBMA Usage in Eastern Europe
17.2.2 cBMA Brands in Eastern Europe
17.2.3 PRP Brands in Eastern Europe
17.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Eastern Europe
MIDDLE EAST
18.1 MIDDLE EAST HYALURONIC ACID VISCOSUPPLEMENTATION
18.1.1 Physician Average Years of Practice in the Middle East
18.1.2 Clinical Settings in the Middle East
18.1.3 HA Viscosupplementation Brands in the Middle East
18.1.4 HA Viscosupplementation Injection Trends in the Middle East
18.1.5 HA Viscosupplementation Brand Purchasing Trends in the Middle East
18.1.6 Brand Adoption Trends in the Middle East
18.1.7 Purchasing Channel Trends in the Middle East
18.2 MIDDLE EAST PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
18.2.1 PRP & cBMA Usage in the Middle East
18.2.2 cBMA Brands in the Middle East
18.2.3 PRP Brands in the Middle East
18.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Middle East
AFRICA
19.1 AFRICA HYALURONIC ACID VISCOSUPPLEMENTATION
19.1.1 Physician Average Years of Practice in Africa
19.1.2 Clinical Settings in Africa
19.1.3 HA Viscosupplementation Brands in Africa
19.1.4 HA Viscosupplementation Injection Trends in Africa
19.1.5 HA Viscosupplementation Brand Purchasing Trends in Africa
19.1.6 Brand Adoption Trends in Africa
19.1.7 Purchasing Channel Trends in Africa
19.2 AFRICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
19.2.1 PRP & cBMA Usage in Africa
19.2.2 cBMA Brands in Africa
19.2.3 PRP Brands in Africa
19.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Africa
ASIA
20.1 ASIA HYALURONIC ACID VISCOSUPPLEMENTATION
20.1.1 Physician Average Years of Practice in Asia
20.1.2 Clinical Settings in Asia
20.1.3 HA Viscosupplementation Brands in Asia
20.1.4 HA Viscosupplementation Injection Trends in Asia
20.1.5 HA Viscosupplementation Brand Purchasing Trends in Asia
20.1.6 Brand Adoption Trends in Asia
20.1.7 Purchasing Channel Trends in Asia
20.2 AFRICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
20.2.1 PRP & cBMA Usage in Asia
20.2.2 cBMA Brands in Asia
20.2.3 PRP Brands in Asia
20.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Asia
APPENDIX
21.1 SURVEY RESPONDENTS BY GEOGRAPHICAL DISTRIBUTION
ABBREVIATIONS
1.1 RESEARCH OVERVIEW
1.2 RESEARCH SERVICES
1.3 SURVEY METHODOLOGY
UNITED STATES
2.1 U.S. HYALURONIC ACID VISCOSUPPLEMENTATION
2.1.1 Physician Average Years of Practice in the U.S.
2.1.2 Clinical Settings in the U.S.
2.1.3 HA Viscosupplementation Brands in the U.S.
2.1.4 HA Viscosupplementation Injection Trends in the U.S.
2.1.5 HA Viscosupplementation Brand Purchasing Trends in the U.S.
2.1.6 Brand Adoption Trends in the U.S.
2.1.7 Purchasing Channel Trends in the U.S.
2.2 U.S. PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
2.2.1 PRP & cBMA Usage in the U.S.
2.2.2 cBMA Brands in the U.S.
2.2.3 PRP Brands in the U.S.
2.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, U.S.
CANADA
3.1 CANADA HYALURONIC ACID VISCOSUPPLEMENTATION
3.1.1 Physician Average Years of Practice in Canada
3.1.2 Clinical Settings of Respondents in Canada
3.1.3 HA Viscosupplementation Brands in Canada
3.1.4 HA Viscosupplementation Injection Trends in Canada
3.1.5 HA Viscosupplementation Brand Purchasing Trends in Canada
3.1.6 Brand Adoption Trends in Canada
3.1.7 Purchasing Channel Trends in Canada
3.2 CANADA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
3.2.1 PRP & cBMA Usage in Canada
3.2.2 cBMA & PRP Brands in Canada
3.2.3 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Canada
UNITED KINGDOM
4.1 U.K. HYALURONIC ACID VISCOSUPPLEMENTATION
4.1.1 Physician Average Years of Practice in the U.K.
4.1.2 Clinical Settings in the U.K.
4.1.3 HA Viscosupplementation Brands in the U.K.
4.1.4 HA Viscosupplementation Injection Trends in the U.K.
4.1.5 HA Viscosupplementation Brand Purchasing Trends in the U.K.
4.1.6 Brand Adoption Trends in the U.K.
4.1.7 Purchasing Channel Trends in the U.K.
4.2 U.K. PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
4.2.1 PRP & cBMA Usage in the U.K.
4.2.2 cBMA & PRP Brands in the U.K.
4.2.3 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, U.K.
ARGENTINA
5.1 ARGENTINA HYALURONIC ACID VISCOSUPPLEMENTATION
5.1.1 Physician Average Years of Practice in Argentina
5.1.2 Clinical Settings in Argentina
5.1.3 HA Viscosupplementation Brands in Argentina
5.1.4 HA Viscosupplementation Injection Trends in Argentina
5.1.5 HA Viscosupplementation Brand Purchasing Trends in Argentina
5.1.6 Brand Adoption Trends in Argentina
5.1.7 Purchasing Channel Trends in Argentina
5.2 ARGENTINA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
5.2.1 PRP & cBMA Usage in Argentina
5.2.2 cBMA Brands in Argentina
5.2.3 PRP Brands in Argentina
5.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Argentina
BRAZIL
6.1 BRAZIL HYALURONIC ACID VISCOSUPPLEMENTATION
6.1.1 Physician Average Years of Practice in Brazil
6.1.2 Clinical Settings in Brazil
6.1.3 HA Viscosupplementation Brands in Brazil
6.1.4 HA Viscosupplementation Injection Trends in Brazil
6.1.5 HA Viscosupplementation Brand Purchasing Trends in Brazil
6.1.6 Brand Adoption Trends in Brazil
6.1.7 Purchasing Channel Trends in Brazil
6.2 BRAZIL PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
6.2.1 PRP & cBMA Usage in Brazil
6.2.2 cBMA Brands in Brazil
6.2.3 PRP Brands in Brazil
6.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Brazil
COLOMBIA
7.1 COLOUMBIA HYALURONIC ACID VISCOSUPPLEMENTATION
7.1.1 Physician Average Years of Practice in Colombia
7.1.2 Clinical Settings in Colombia
7.1.3 HA Viscosupplementation Brands in Colombia
7.1.4 HA Viscosupplementation Injection Trends in Colombia
7.1.5 HA Viscosupplementation Brand Purchasing Trends in Colombia
7.1.6 Brand Adoption Trends in Colombia
7.1.7 Purchasing Channel Trends in Colombia
7.2 COLOMBIA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
7.2.1 PRP & cBMA Usage in Colombia
7.2.2 cBMA Brands in Colombia
7.2.3 PRP Brands in Colombia
7.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Colombia
VENEZUELA
8.1 VENEZUELA HYALURONIC ACID VISCOSUPPLEMENTATION
8.1.1 Physician Average Years of Practice in Venezuela
8.1.2 Clinical Settings in Venezuela
8.1.3 HA Viscosupplementation Brands in Venezuela
8.1.4 HA Viscosupplementation Injection Trends in Venezuela
8.1.5 HA Viscosupplementation Brand Purchasing Trends in Venezuela
8.1.6 Brand Adoption Trends in Venezuela
8.1.7 Purchasing Channel Trends in Venezuela
8.2 VENEZUELA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
8.2.1 PRP & cBMA Usage in Venezuela
8.2.2 cBMA Brands in Venezuela
8.2.3 PRP Brands in Venezuela
8.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Venezuela
MEXICO
9.1 MEXICO HYALURONIC ACID VISCOSUPPLEMENTATION
9.1.1 Physician Average Years of Practice in Mexico
9.1.2 Clinical Settings in Mexico
9.1.3 HA Viscosupplementation Brands in Mexico
9.1.4 HA Viscosupplementation Injection Trends in Mexico
9.1.5 HA Viscosupplementation Brand Purchasing Trends in Mexico
9.1.6 Brand Adoption Trends in Mexico
9.1.7 Purchasing Channel Trends in Mexico
9.2 MEXICO PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
9.2.1 PRP & cBMA Usage in Mexico
9.2.2 cBMA Brands in Mexico
9.2.3 PRP Brands in Mexico
9.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Mexico
DOMINICAN REPUBLIC
10.1 DOMINICAN REPUBLIC HYALURONIC ACID VISCOSUPPLEMENTATION
10.1.1 Physician Average Years of Practice in Dominican Republic
10.1.2 Clinical Settings in Dominican Republic
10.1.3 HA Viscosupplementation Brands in Dominican Republic
10.1.4 HA Viscosupplementation Injection Trends in Dominican Republic
10.1.5 HA Viscosupplementation Brand Purchasing Trends in Dominican Republic
10.1.6 Brand Adoption Trends in Dominican Republic
10.1.7 Purchasing Channel Trends in Dominican Republic
10.2 DOMINICAN REPUBLIC PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
10.2.1 PRP & cBMA Usage in Dominican Republic
10.2.2 cBMA Brands in Dominican Republic
10.2.3 PRP Brands in Dominican Republic
10.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Dominican Republic
JORDAN
11.1 JORDAN HYALURONIC ACID VISCOSUPPLEMENTATION
11.1.1 Physician Average Years of Practice in Jordan
11.1.2 Clinical Settings in Jordan
11.1.3 HA Viscosupplementation Brands in Jordan
11.1.4 HA Viscosupplementation Injection Trends in Jordan
11.1.5 HA Viscosupplementation Brand Purchasing Trends in Jordan
11.1.6 Brand Adoption Trends in Jordan
11.1.7 Purchasing Channel Trends in Jordan
11.2 JORDAN PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
11.2.1 PRP & cBMA Usage in Jordan
11.2.2 cBMA Brands in Jordan
11.2.3 PRP Brands in Jordan
11.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Jordan
INDIA
12.1 INDIA HYALURONIC ACID VISCOSUPPLEMENTATION
12.1.1 Physician Average Years of Practice in India
12.1.2 Clinical Settings in India
12.1.3 HA Viscosupplementation Brands in India
12.1.4 HA Viscosupplementation Injection Trends in India
12.1.5 HA Viscosupplementation Brand Purchasing Trends in India
12.1.6 Brand Adoption Trends in India
12.1.7 Purchasing Channel Trends in India
12.2 INDIA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
12.2.1 PRP & cBMA Usage in India
12.2.2 cBMA Brands in India
12.2.3 PRP Brands in India
12.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, India
NORTH AMERICA
13.1 NORTH AMERICA HYALURONIC ACID VISCOSUPPLEMENTATION
13.1.1 Physician Average Years of Practice in North America
13.1.2 Clinical Settings in North America
13.1.3 HA Viscosupplementation Brands in North America
13.1.4 HA Viscosupplementation Injection Trends in North America
13.1.5 HA Viscosupplementation Brand Purchasing Trends in North America
13.1.6 Brand Adoption Trends in North America
13.1.7 Purchasing Channel Trends in North America
13.2 NORTH AMERICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
13.2.1 PRP & cBMA Usage in North America
13.2.2 cBMA Brands in North America
13.2.3 PRP Brands in North America
13.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, North America
SOUTH AMERICA
14.1 SOUTH AMERICA HYALURONIC ACID VISCOSUPPLEMENTATION
14.1.1 Physician Average Years of Practice in South America
14.1.2 Clinical Settings in South America
14.1.3 HA Viscosupplementation Brands in South America
14.1.4 HA Viscosupplementation Injection Trends in South America
14.1.5 HA Viscosupplementation Brand Purchasing Trends in South America
14.1.6 Brand Adoption Trends in South America
14.1.7 Purchasing Channel Trends in South America
14.2 SOUTH AMERICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
14.2.1 PRP & cBMA Usage in South America
14.2.2 cBMA Brands in South America
14.2.3 PRP Brands in South America
14.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, South America
CENTRAL AMERICA & THE CARRIBEAN
15.1 SOUTH AMERICA & THE CARIBBEAN HYALURONIC ACID VISCOSUPPLEMENTATION
15.1.1 Physician Average Years of Practice in Central America & the Caribbean
15.1.2 Clinical Settings in Central America & the Caribbean
15.1.3 HA Viscosupplementation Brands in Central America & the Caribbean
15.1.4 HA Viscosupplementation Injection Trends in Central America & the Caribbean
15.1.5 HA Viscosupplementation Brand Purchasing Trends in Central America & the Caribbean
15.1.6 Brand Adoption Trends in Central America & the Caribbean
15.1.7 Purchasing Channel Trends in Central America & the Caribbean
15.2 CENTRAL AMERICA & THE CARIBBEAN PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
15.2.1 PRP & cBMA Usage in Central America & the Caribbean
15.2.2 cBMA Brands in Central America & the Caribbean
15.2.3 PRP Brands in Central America & the Caribbean
15.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Central America & the Caribbean
WESTERN EUROPE
16.1 WESTERN EUROPE HYALURONIC ACID VISCOSUPPLEMENTATION
16.1.1 Physician Average Years of Practice in Western Europe
16.1.2 Clinical Settings in Western Europe
16.1.3 HA Viscosupplementation Brands in Western Europe
16.1.4 HA Viscosupplementation Injection Trends in Western Europe
16.1.5 HA Viscosupplementation Brand Purchasing Trends in Western Europe
16.1.6 Brand Adoption Trends in Western Europe
16.1.7 Purchasing Channel Trends in Western Europe
16.2 WESTERN EUROPE PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
16.2.1 PRP & cBMA Usage in Western Europe
16.2.2 cBMA Brands in Western Europe
16.2.3 PRP Brands in Western Europe
16.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Western Europe
EASTERN EUROPE
17.1 EASTERN EUROPE HYALURONIC ACID VISCOSUPPLEMENTATION
17.1.1 Physician Average Years of Practice in Eastern Europe
17.1.2 Clinical Settings in Eastern Europe
17.1.3 HA Viscosupplementation Brands in Eastern Europe
17.1.4 HA Viscosupplementation Injection Trends in Eastern Europe
17.1.5 HA Viscosupplementation Brand Purchasing Trends in Eastern Europe
17.1.6 Brand Adoption Trends in Eastern Europe
17.1.7 Purchasing Channel Trends in Eastern Europe
17.2 EASTERN EUROPE PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
17.2.1 PRP & cBMA Usage in Eastern Europe
17.2.2 cBMA Brands in Eastern Europe
17.2.3 PRP Brands in Eastern Europe
17.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Eastern Europe
MIDDLE EAST
18.1 MIDDLE EAST HYALURONIC ACID VISCOSUPPLEMENTATION
18.1.1 Physician Average Years of Practice in the Middle East
18.1.2 Clinical Settings in the Middle East
18.1.3 HA Viscosupplementation Brands in the Middle East
18.1.4 HA Viscosupplementation Injection Trends in the Middle East
18.1.5 HA Viscosupplementation Brand Purchasing Trends in the Middle East
18.1.6 Brand Adoption Trends in the Middle East
18.1.7 Purchasing Channel Trends in the Middle East
18.2 MIDDLE EAST PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
18.2.1 PRP & cBMA Usage in the Middle East
18.2.2 cBMA Brands in the Middle East
18.2.3 PRP Brands in the Middle East
18.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Middle East
AFRICA
19.1 AFRICA HYALURONIC ACID VISCOSUPPLEMENTATION
19.1.1 Physician Average Years of Practice in Africa
19.1.2 Clinical Settings in Africa
19.1.3 HA Viscosupplementation Brands in Africa
19.1.4 HA Viscosupplementation Injection Trends in Africa
19.1.5 HA Viscosupplementation Brand Purchasing Trends in Africa
19.1.6 Brand Adoption Trends in Africa
19.1.7 Purchasing Channel Trends in Africa
19.2 AFRICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
19.2.1 PRP & cBMA Usage in Africa
19.2.2 cBMA Brands in Africa
19.2.3 PRP Brands in Africa
19.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Africa
ASIA
20.1 ASIA HYALURONIC ACID VISCOSUPPLEMENTATION
20.1.1 Physician Average Years of Practice in Asia
20.1.2 Clinical Settings in Asia
20.1.3 HA Viscosupplementation Brands in Asia
20.1.4 HA Viscosupplementation Injection Trends in Asia
20.1.5 HA Viscosupplementation Brand Purchasing Trends in Asia
20.1.6 Brand Adoption Trends in Asia
20.1.7 Purchasing Channel Trends in Asia
20.2 AFRICA PLATELET RICH PLASMA & CONCENTRATED BONE MARROW ASPIRATE
20.2.1 PRP & cBMA Usage in Asia
20.2.2 cBMA Brands in Asia
20.2.3 PRP Brands in Asia
20.2.4 PRP Usage for Tendonitis/Tendonosis & Osteoarthritis, Asia
APPENDIX
21.1 SURVEY RESPONDENTS BY GEOGRAPHICAL DISTRIBUTION
ABBREVIATIONS
